HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

295.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 352.00p
  • 52 Week Low: 173.60p
  • Currency: UK Pounds
  • Shares Issued: 871.26m
  • Volume: 233
  • Market Cap: £2,570.23m
  • RiskGrade: 226

Wednesday broker round-up UPDATE

Date: Wednesday 09 Oct 2013

LONDON (ShareCast) - Air Partner: Liberum Capital initiates with a target price of 555p and a buy recommendation.

Alent: Credit Suisse moves target price from 420p to 430p and keeps an outperform rating.

AZ Electronic Materials: Credit Suisse revises target price from 350p to 330p, while staying with its neutral rating.

Barclays: Deutsche Bank cuts target price from 370p to 325p, while its buy recommendation remains unchanged.

Barratt Developments: Goldman Sachs upgrades to buy with a target price of 371p.

Bellway: Panmure Gordon moves target price from 1383p to 1396p and upgrades from hold to buy.

Bovis Homes Group: Goldman Sachs upgrades to buy with a target price of 668p.

British Sky Broadcasting: Investec downgrades from hold to reduce with a target price of 825p.

Chemring Group: Barclays upgrades to overweight with a target price of 270p.

Close Brothers Group: Berenberg increases target price from 1150p to 1330p and leaves its buy recommendation unaltered.

Compass Group: Deutsche Bank lowers target price from 1000p to 967p staying with its buy recommendation.

Crest Nicholson Holdings: Goldman Sachs initiates with a buy recommendation.

Domino Printing Sciences: Barclays upgrades to overweight with a target price of 670p.

Halfords Group: Deutsche Bank ups target price from 300p to 330p, but still recommends selling.

Halma: Barclays downgrades to equal-weight with a target price of 540p.

Hellermann Tyton Group: JP Morgan shifts target price from 285p to 295p reiterating an overweight rating.

Hutchison China Meditech: Panmure Gordon raises target price from 600p to 725p and retains a buy recommendation.

IMI: Barclays downgrades to equal-weight with a target price of 1320p.

InterContinental Hotels Group: Nomura reduces target price from 2066p to 1880p, while maintaining its neutral rating.

Kentz Corporation: Liberum Capital upgrades to buy with a target price of 610p.

Morgan Advanced Materials: Barclays downgrades to equal-weight.

Optos: Investec ups target price from 124p to 141p and keeps a reduce rating.

Petroceltic: Liberum Capital reduces target price from 278p to 218p and reiterates a buy recommendation.

QinetiQ: Barclays upgrades to overweight with a target price of 190p.

Synthomer: Bank of America ups target price from 220p to 250p and retains a neutral rating.

Thorntons: Investec moves target price from 112p to 124p leaving its buy recommendation unchanged.

Vedanta Resources: Morgan Stanley downgrades to underweight with a target price of 1140p.

Wolseley: Deutsche Bank raises target price from 3400p to 3551p maintaining a buy recommendation.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 295.00p
Change Today -3.00p
% Change -1.01 %
52 Week High 352.00p
52 Week Low 173.60p
Volume 233
Shares Issued 871.26m
Market Cap £2,570.23m
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.33% below the market average73.33% below the market average73.33% below the market average73.33% below the market average73.33% below the market average
49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average49.02% below the sector average
Price Trend
59.26% above the market average59.26% above the market average59.26% above the market average59.26% above the market average59.26% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average
Income Not Available
Growth
67.67% above the market average67.67% above the market average67.67% above the market average67.67% above the market average67.67% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

HCM Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:27 65 @ 296.97p
15:30 1 @ 294.00p
15:29 26 @ 294.00p
15:29 1 @ 294.00p
15:23 84 @ 296.97p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page